Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 16389 [2020-06073]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 56 / Monday, March 23, 2020 / Notices
of the ITAAC are met; and (3) any NRC
inspections for the ITAAC have been
completed and any ITAAC findings
associated with that ITAAC have been
closed. The NRC’s review process for
IPCNs is similar to that for ICNs but
focuses on how the licensee addressed
the new, material information giving
rise to the IPCN.
The NRC staff’s determination of the
successful completion of these ITAAC is
based on information available at this
time and is subject to the licensee’s
ability to maintain the condition that
the acceptance criteria are met. If the
NRC staff receives new information that
suggests the NRC staff’s determination
on any of these ITAAC is incorrect, then
the NRC staff will determine whether to
reopen that ITAAC (including
withdrawing the NRC staff’s
determination on that ITAAC). The NRC
staff’s determination will be used to
support a subsequent finding, pursuant
to 10 CFR 52.103(g), at the end of
construction that all acceptance criteria
in the combined license are met. The
ITAAC closure process is not finalized
for these ITAAC until the NRC makes an
affirmative finding under 10 CFR
52.103(g). Any future updates to the
status of these ITAAC will be reflected
on the NRC’s website at https://
www.nrc.gov/reactors/new-reactors/
oversight/itaac.html.
This notice fulfills the NRC staff’s
obligations under 10 CFR 52.99(e)(1) to
publish a notice in the Federal Register
of the NRC staff’s determination of the
successful completion of inspections,
tests, and analyses.
jbell on DSKJLSW7X2PROD with NOTICES
Vogtle Electric Generating Plant Unit 3,
Docket No. 5200025
A complete list of the review status
for VEGP Unit 3 ITAAC, including the
submission date and ADAMS Accession
Number for each ICN received, the
ADAMS Accession Number for each
VEF, and the ADAMS Accession
Numbers for the inspection reports
associated with these specific ITAAC,
can be found on the NRC’s website at
https://www.nrc.gov/reactors/newreactors/new-licensing-files/vog3icnsr.pdf.
Vogtle Electric Generating Plant Unit 4,
Docket No. 5200026
A complete list of the review status
for VEGP Unit 4 ITAAC, including the
submission date and ADAMS accession
number for each ICN and IPCN received,
the ADAMS accession number for each
VEF, and the ADAMS accession
numbers for the inspection reports
associated with these specific ITAAC,
can be found on the NRC’s website at
https://www.nrc.gov/reactors/new-
VerDate Sep<11>2014
17:26 Mar 20, 2020
Jkt 250001
reactors/new-licensing-files/vog4icnsr.pdf.
Dated at Rockville, Maryland, this 17th day
of March 2020.
For the Nuclear Regulatory Commission.
Victor E. Hall,
Chief, Vogtle Project Office, Office of Nuclear
Reactor Regulation.
[FR Doc. 2020–06057 Filed 3–20–20; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
Advisory Committee on the Medical
Uses of Isotopes: Meeting Notice
U.S. Nuclear Regulatory
Commission.
ACTION: Re-notice of meeting.
AGENCY:
The U.S. Nuclear Regulatory
Commission (NRC) will convene a
meeting of the Advisory Committee on
the Medical Uses of Isotopes (ACMUI)
on March 30, 2020. This meeting notice,
published in the Federal Register on
February 19, 2020, is being re-noticed to
inform members of the public that this
meeting will now be conducted on
March 30, 2020 via teleconference.
DATES: March 30, 2020 from 9:30 a.m. to
5:00 p.m. Eastern Standard Time.
FOR FURTHER INFORMATION CONTACT: Ms.
Kellee Jamerson, email:
Kellee.Jamerson@nrc.gov, telephone:
(301) 415–7408.
SUPPLEMENTARY INFORMATION: The
current agenda and any updates are
available at https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/
2020.html or by emailing Ms. Kellee
Jamerson at the contact information
above. The agenda is subject to change.
Purpose: Discuss issues related to 10
CFR part 35 Medical Use of Byproduct
Material.
Public Participation: Any member of
the public who wishes to participate in
the meeting should contact Ms.
Jamerson using the information above.
The meeting will also use the WebEx
application.
SUMMARY:
Conduct of the Meeting
Darlene Metter, M.D. will chair the
meeting. Dr. Metter will conduct the
meeting in a manner that will facilitate
the orderly conduct of business. The
following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a
written statement should submit an
electronic copy to Ms. Jamerson using
the contact information listed above. All
submittals must be received by March
25, 2020, three business days before the
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
16389
meeting, and must pertain to the topics
on the agenda for the meeting.
2. Questions and comments from
members of the public will be permitted
at designated times during the meeting,
at the discretion of the ACMUI
Chairman.
3. The draft transcript and meeting
summary will be available on the
ACMUI’s website https://www.nrc.gov/
reading-rm/doc-collections/acmui/
meetings/2020.html on or about May 12,
2020.
This meeting will be held in
accordance with the Atomic Energy Act
of 1954, as amended (primarily Section
161a); the Federal Advisory Committee
Act (5 U.S.C. App); and the
Commission’s regulations in Title 10 of
the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 18th day
of March, 2020.
For the U.S. Nuclear Regulatory
Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020–06073 Filed 3–20–20; 8:45 am]
BILLING CODE 7590–01–P
OFFICE OF PERSONNEL
MANAGEMENT
Submission for Review: 3206–0216, We
Need Important Information About
Your Eligibility for Social Security
Disability Benefits, RI 98–7
Office of Personnel
Management.
ACTION: 60-Day notice and request for
comments.
AGENCY:
The Retirement Services,
Office of Personnel Management (OPM)
offers the general public and other
federal agencies the opportunity to
comment on a revised information
collection request (ICR), We Need
Important Information About Your
Eligibility for Social Security Disability
Benefits, RI 98–7.
DATES: Comments are encouraged and
will be accepted until May 22, 2020.
ADDRESSES: You may submit comments,
identified by docket number and title,
by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
Instructions: All submissions received
must include the agency name, docket
number and title for this Federal
Register document. The general policy
for comments and other submissions
from members of the public is to make
these submissions available for public
viewing on the internet at https://
SUMMARY:
E:\FR\FM\23MRN1.SGM
23MRN1
]]>Agencies
[Federal Register Volume 85, Number 56 (Monday, March 23, 2020)]
[Notices]
[Page 16389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06073]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
Advisory Committee on the Medical Uses of Isotopes: Meeting
Notice
AGENCY: U.S. Nuclear Regulatory Commission.
ACTION: Re-notice of meeting.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a
meeting of the Advisory Committee on the Medical Uses of Isotopes
(ACMUI) on March 30, 2020. This meeting notice, published in the
Federal Register on February 19, 2020, is being re-noticed to inform
members of the public that this meeting will now be conducted on March
30, 2020 via teleconference.
DATES: March 30, 2020 from 9:30 a.m. to 5:00 p.m. Eastern Standard
Time.
FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email:
[email protected], telephone: (301) 415-7408.
SUPPLEMENTARY INFORMATION: The current agenda and any updates are
available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html or by emailing Ms. Kellee Jamerson at the contact
information above. The agenda is subject to change.
Purpose: Discuss issues related to 10 CFR part 35 Medical Use of
Byproduct Material.
Public Participation: Any member of the public who wishes to
participate in the meeting should contact Ms. Jamerson using the
information above. The meeting will also use the WebEx application.
Conduct of the Meeting
Darlene Metter, M.D. will chair the meeting. Dr. Metter will
conduct the meeting in a manner that will facilitate the orderly
conduct of business. The following procedures apply to public
participation in the meeting:
1. Persons who wish to provide a written statement should submit an
electronic copy to Ms. Jamerson using the contact information listed
above. All submittals must be received by March 25, 2020, three
business days before the meeting, and must pertain to the topics on the
agenda for the meeting.
2. Questions and comments from members of the public will be
permitted at designated times during the meeting, at the discretion of
the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on
the ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about May 12, 2020.
This meeting will be held in accordance with the Atomic Energy Act
of 1954, as amended (primarily Section 161a); the Federal Advisory
Committee Act (5 U.S.C. App); and the Commission's regulations in Title
10 of the Code of Federal Regulations, Part 7.
Dated at Rockville, Maryland this 18th day of March, 2020.
For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-06073 Filed 3-20-20; 8:45 am]
BILLING CODE 7590-01-P
